|
Re: AACR 2018
|
2
|
Zenith Epigenetics
|
Mar 06, 2018 01:15PM
|
|
Re: AACR 2018
|
2
|
Zenith Epigenetics
|
Mar 06, 2018 01:24PM
|
|
Re: Statistical Considerations
|
1
|
Resverlogix Corp.
|
Mar 06, 2018 03:04PM
|
|
Re: Chinese Takeovers
|
1
|
Zenith Epigenetics
|
Mar 07, 2018 10:49AM
|
|
Re: Statistical Considerations
|
|
Resverlogix Corp.
|
Mar 07, 2018 10:57AM
|
|
Re: Statistical Considerations
|
1
|
Resverlogix Corp.
|
Mar 07, 2018 01:42PM
|
|
Re: Chinese Takeovers
|
|
Zenith Epigenetics
|
Mar 07, 2018 03:56PM
|
|
Of interest during this pending financing period
|
2
|
Resverlogix Corp.
|
Mar 07, 2018 04:31PM
|
|
Re: Statistical Considerations
|
4
|
Resverlogix Corp.
|
Mar 07, 2018 07:24PM
|
|
Re: Chinese Takeovers
|
2
|
Zenith Epigenetics
|
Mar 08, 2018 11:53AM
|
|
Re: Statistical Considerations
|
1
|
Resverlogix Corp.
|
Mar 08, 2018 12:03PM
|
|
Re: Statistical Considerations
|
|
Resverlogix Corp.
|
Mar 08, 2018 03:47PM
|
|
Re: Statistical Considerations
|
|
Resverlogix Corp.
|
Mar 08, 2018 07:06PM
|
|
Re: TSX Review
|
2
|
Resverlogix Corp.
|
Mar 13, 2018 09:02PM
|
|
Re: TSX Review
|
3
|
Resverlogix Corp.
|
Mar 15, 2018 01:18PM
|
|
Re: MD&A and Financials up on SEDAR
|
1
|
Resverlogix Corp.
|
Mar 18, 2018 12:16PM
|
|
Re: time to add/3 vs 5 pt. MACE
|
1
|
Resverlogix Corp.
|
Mar 21, 2018 10:34PM
|
|
Re: Reports of exempt distribution on SEDAR
|
3
|
Resverlogix Corp.
|
Mar 29, 2018 03:59PM
|
|
Re: Que sera sera....
|
1
|
Resverlogix Corp.
|
Apr 03, 2018 11:54AM
|
|
Re: Que sera sera....
|
2
|
Resverlogix Corp.
|
Apr 06, 2018 02:51PM
|
